Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2Cl.Pt.2H3N |
Molecular Weight | 300.051 |
Optical Activity | NONE |
Additional Stereochemistry | Yes |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | SP-4-2 |
SHOW SMILES / InChI
SMILES
N.N.[Cl-].[Cl-].[Pt++]
InChI
InChIKey=LXZZYRPGZAFOLE-UHFFFAOYSA-L
InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
Molecular Formula | H3N |
Molecular Weight | 17.0305 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Pt |
Molecular Weight | 195.084 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:18:53 UTC 2023
by
admin
on
Fri Dec 15 15:18:53 UTC 2023
|
Record UNII |
Q20Q21Q62J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C798
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
WHO-ATC |
L01XA01
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
238607
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
221906
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
WHO-VATC |
QL01XA01
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
NDF-RT |
N0000175413
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
134800
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
536616
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
447514
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
NDF-RT |
N0000175073
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/13/1169
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
867921
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
LIVERTOX |
NBK548160
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
557716
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
NCI_THESAURUS |
C1450
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
783620
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
133200
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D002945
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
DTXSID4024983
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
15663-27-1
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
100000088223
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
CHEMBL11359
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
4392
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
119875
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
C376
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
Q20Q21Q62J
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
84691
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
Cisplatin
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
3939
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
239-733-8
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
5343
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
4426
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
27899
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
CISPLATIN
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | Description: White to yellowish crystals or a yellow powder.Solubility: Slightly soluble in water; sparingly soluble in dimethylformamide R; practically insoluble in methanol R.Category: Cytotoxic drug.Storage: Cisplatin should be kept in a tightly closed container, protected from light, and stored at a temperature between 2 and 8?C.Additional information: CAUTION: Cisplatin must be handled with care, avoiding contact with the skin and inhalation of airborneparticles.When heated, it blackens at about 270 ?C with decomposition. | ||
|
CISPLATIN
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
1134357
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
DB00515
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
m3586
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | Merck Index | ||
|
Q20Q21Q62J
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | |||
|
2555
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB07483MIG
Created by
admin on Fri Dec 15 15:18:53 UTC 2023 , Edited by admin on Fri Dec 15 15:18:53 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
OCCURS INTRACELLULARLY
|
||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
METABOLITE ACTIVE -> PRODRUG |
OCCURS INTRACELLULARLY
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
ASSAY (HPLC)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||